The Limited Times

Now you can see non-English news...

WuXi Junuo plans to raise a maximum of 2.3 billion yuan for listing in Hong Kong

2020-05-05T09:21:01.744Z


According to sources quoted by the foreign news agency, the mainland cell therapy company JW Therapeutics has decided to list in Hong Kong and plans to raise 200 million to 300 million US dollars (about 1.55 billion to 2.33 billion Hong Kong dollars).


Financial News

Written by: Huang Youhua

2020-05-05 17:16

Last update date: 2020-05-05 17:16

According to sources quoted by the foreign news agency, the mainland cell therapy company JW Therapeutics has decided to list in Hong Kong and plans to raise US $ 200 million to US $ 300 million (approximately US $ 1.55 billion to US $ 2.33 billion). Goldman Sachs and UBS arrangements.

As early as 2018, WuXi Junuo has completed a Series A financing of approximately US $ 90 million (approximately HK $ 702 million). Investors include Temasek and Sequoia.

WuXiJinuo is a cell therapy company co-founded by WuXi PharmaTech (2359) and Juno Therapeutics in 2016.

Shangfang Chinese medicine masks are drawn again! By 5.6 nights, BFE 99% and PFE 97% for independent packaging

New Crown Pneumonia | Unemployed Han Pharmacy Stealed Three Boxes of Masks for Self-Use

【New Coronary Pneumonia】 Trump recommends anti-malarial drug "hydroxychloroquine" again

Biotechnology IPO

Source: hk1

All news articles on 2020-05-05

You may like

News/Politics 2024-01-29T18:39:22.190Z
Life/Entertain 2024-02-28T02:13:18.403Z

Trends 24h

News/Politics 2024-03-28T06:04:53.137Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.